Prevalence and effect of myocardial injury after transcatheter aortic valve replacement.

[1]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.

[2]  R. Virmani,et al.  Direct percutaneous left ventricular access and port closure: pre-clinical feasibility. , 2011, JACC. Cardiovascular interventions.

[3]  J. Francis,et al.  Early diagnosis of perioperative myocardial infarction after coronary bypass grafting: a study using biomarkers and cardiac magnetic resonance imaging. , 2011, The Annals of thoracic surgery.

[4]  Robert M. Minutello,et al.  Prognostic value of cardiac troponin‐I or troponin‐T elevation following nonemergent percutaneous coronary intervention: A meta‐analysis , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[5]  P. Pibarot,et al.  Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. , 2011, Journal of the American College of Cardiology.

[6]  V. Hasselblad,et al.  Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. , 2011, JAMA.

[7]  Pascal Vranckx,et al.  Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. , 2011, Journal of the American College of Cardiology.

[8]  P. Serruys,et al.  Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium , 2010, European heart journal.

[9]  G. Niccoli,et al.  A case of myocardial infarction effectively treated by emergency coronary stenting soon after a Bentall-De Bono aortic surgery. , 2010, Cardiovascular revascularization medicine : including molecular interventions.

[10]  Denis Xavier,et al.  Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial , 2008, The Lancet.

[11]  C. Memmola,et al.  Cardiac troponin I release after coronary artery bypass grafting operation: effects on operative and midterm survival. , 2005, The Annals of thoracic surgery.

[12]  J. Ioannidis,et al.  Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. , 2003, Journal of the American College of Cardiology.

[13]  R. Stevens,et al.  Pharmacologic Myocardial Protection in Patients Undergoing Noncardiac Surgery: A Quantitative Systematic Review , 2003, Anesthesia and analgesia.

[14]  E. Topol,et al.  Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. , 2002, Journal of the American College of Cardiology.

[15]  E. Topol,et al.  Frequency and long-term impact of myonecrosis after coronary stenting. , 2002, European heart journal.

[16]  B. Chaitman,et al.  Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial. , 2001, Journal of the American College of Cardiology.

[17]  Samin K. Sharma,et al.  Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention. , 1999, Journal of the American College of Cardiology.

[18]  R. Bonow,et al.  Prognostic implication of creatine kinase elevation following elective coronary artery interventions. , 1997, JAMA.

[19]  E. Topol,et al.  The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures. , 1996, Circulation.

[20]  R. Califf,et al.  Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). , 1995, Journal of the American College of Cardiology.

[21]  G. Niccoli,et al.  Erratum to A case of myocardial infarction effectively treated by emergency coronary stenting soon after a Bentall-De Bono aortic surgery (Cardiovasc Revasc Med 2010;11(4):263) , 2011 .

[22]  D. Ardissino,et al.  Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. , 2005, European heart journal.